Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax
Safety, Efficacy Tests Begin On Controversial Vaccine
April 11th, 2001
New tests on the effectiveness and safety of the anthrax vaccine were scheduled to begin at the end of March 2001. The battery of studies, coordinated by the U.S. Centers for Disease Control and Prevention, the lead federal agency charged with protecting health and safety, could help answer lingering concerns about the vaccine. The vaccine is made solely in the United States by BioPort Corp. in Lansing, Michigan. The CDC studies may help determine if the vaccine can be effective with fewer doses, and how it may best be administered to military troops to reduce adverse reactions, according to a story in the March 23, 2000, edition of the Lansing...
Source: Vaccine Weekly (2001-04-11)
|
